The Next Decade of Advanced Prostate Cancer Clinical Trials: A Data-Driven Framework
An international expert committee has updated the standard criteria for clinical trial design in prostate oncology. By modernising imaging and biomarker definitions, this framework aims to optimise therapy development and refine precision medicine.
By Armstrong, Morris, Abida, Aggarwal, Antonarakis, Attard, Beltran, Bryce, Carducci, Cheng, Chen, Chi, Childs, Dahut, Emmett, Fizazi, Gafita, George, Hermann, Hofman, Hope, Hussain, Kelly, Kessler, Kuo, Lang, Liu, Marshall, Morgans, McKay, Nanus, Nelson, Paller, Reichert, Ryan, Sartor, Schöder, Schwartz, Sharifi, Stadler, Stein, Sternberg, Szmulewitz, Tagawa, Sokolova, Wyatt, Yamoah, Yu, Halabi, Scher, for the PCWG4 Writing Group, Alumkal, Aparicio, Barata, Drake, Graff, Hamid, Heath, Nauseef, Lage, Mallak, Patnaik, Prepelica, Rathkopf, Rettig, Rowe, Slovin, Taplin, Zorko
